Table 1.

In vitro functional activity of monoclonal anticardiolipin Immunoglobulin G (IgG) and control IgG

Control IgGCIC 01CIC 03CIC 11CIC 14CIC 19
LA activity using the dRVVT test       
 Clotting time(s) dRVVT* 43.5 ± 0.7 60.1 ± 0.8 45.85 ± 1.35 45.25 ± 0.45 45 ± 0.8 45.1 ± 1.2  
 Confirmatory test NA 46.4 ± 0.6 NA NA NA NA 
 Ratio — 1.29 — — — — 
Percentage of inhibition
of thrombin generation 
      
 mAb concentration       
  1 μg/mL 12 14  5  
  5 μg/mL 15 20 16 12  
  10 μg/mL 32 45 20 16  
  20 μg/mL 58 ND ND 18 18 
Control IgGCIC 01CIC 03CIC 11CIC 14CIC 19
LA activity using the dRVVT test       
 Clotting time(s) dRVVT* 43.5 ± 0.7 60.1 ± 0.8 45.85 ± 1.35 45.25 ± 0.45 45 ± 0.8 45.1 ± 1.2  
 Confirmatory test NA 46.4 ± 0.6 NA NA NA NA 
 Ratio — 1.29 — — — — 
Percentage of inhibition
of thrombin generation 
      
 mAb concentration       
  1 μg/mL 12 14  5  
  5 μg/mL 15 20 16 12  
  10 μg/mL 32 45 20 16  
  20 μg/mL 58 ND ND 18 18 

LA indicates lupus anticoagulant; dRVVT, dilute Russell's viper venom test; mAb, monoclonal antibodies; NA, not applicable, because only the samples significantly prolonging the dRVVT required a confirmatory test (see “Patient, materials, and methods”); ND, not done.

*

Each figure in the row represents an average of 2 tests.

The clotting times of dRVVT/dRVVT confirmatory test.

Close Modal

or Create an Account

Close Modal
Close Modal